Diffusion Tensor Imaging in Dementia. Howard Rosen UCSF Department of Neurology Memory and Aging Center

Similar documents
Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Molecular Imaging Heterogeneity of Clinically Defined AD

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

Frontotemporal dementia:

review of existing studies on ASL in dementia Marion Smits, MD PhD

I do not have any disclosures

Confronting the Clinical Challenges of Frontotemporal Dementia

Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre

Differential diagnosis of Frontotemporal Dementia FTLD using visual rating scales

Form D1: Clinician Diagnosis

FTD basics! Etienne de Villers-Sidani, MD!

NIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14.

Mild Cognitive Impairment (MCI)

LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

Non Alzheimer Dementias

Diagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16

Neuro degenerative PET image from FDG, amyloid to Tau

Dr Fiona Kumfor University of Sydney

Differential Diagnosis

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.

Prof Tim Anderson. Neurologist University of Otago Christchurch

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

Assessing and Managing the Patient with Cognitive Decline

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009

Is DTI Increasing the Connectivity Between the Magnet Suite and the Clinic?

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer

Neuropathology of Neurodegenerative Disorders Prof. Jillian Kril

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

brain MRI for neuropsychiatrists: what do you need to know

Diffusion Tensor Imaging in Psychiatry

Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia

Provider Led Entity. CDI Quality Institute PLE Neurocognitive Disorders AUC 02/05/2019

Early Diagnosis of Alzheimer s Disease and MCI via Imaging and Pattern Analysis Methods. Christos Davatzikos, Ph.D.

Network-Based Spread in AD: Evidence from Multi-Modal Human Neuroimaging

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota

Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia

Recruitment of ADC Participants

What APS Workers Need to Know about Frontotemporal, Lewy Body and Vascular Dementias

A Fresh View of Cognitive Disorders in Older Adults: New Classification and Screening Strategies

Moving Targets: An Update on Diagnosing Dementia in the Clinic

Selective Vulnerability of von Economo Neurons in Frontotemporal Dementia

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

Common Forms of Dementia Handout Package

Frontotemporal Degeneration

NACC Minimum Data Set (MDS) Public Data Element Dictionary

Biomarkers: Translating Research into Clinical Practice

Telencephalon (Cerebral Hemisphere)

doi: /brain/awr198 Brain 2011: 134;

Funding: NIDCF UL1 DE019583, NIA RL1 AG032119, NINDS RL1 NS062412, NIDA TL1 DA

On-line Table 1: Dementia diagnoses and related ICD codes for the diagnostic groups a

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

Grey and white matter brain network changes in frontotemporal dementia subtypes

Structural MRI in Frontotemporal Dementia: Comparisons between Hippocampal Volumetry, Tensor- Based Morphometry and Voxel-Based Morphometry

Piano playing skills in a patient with frontotemporal dementia: A longitudinal case study

Part 2: Early detection, assessment and treatment in relation to the new guidelines. Christopher Patterson McMaster University

An integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer s Disease

Differentiating Dementia Diagnoses

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

Neuroimaging Findings in Young Drinkers: Does Teenage Drinking Harm the Brain? Susan F. Tapert, Ph.D. University of California, San Diego

PET ligands and metabolic brain imaging Prof. Karl Herholz

Dementia: It s Not Always Alzheimer s

doi: /brain/awr099 Brain 2011: 134; White matter damage in primary progressive aphasias: a diffusion tensor tractography study

Geri R Hall, PhD, GCNS, FAAN Advanced Practice Nurse Emeritus Banner Alzheimer s Institute

Brain & Language 127 (2013) Contents lists available at SciVerse ScienceDirect. Brain & Language

2016 Programs & Information

Form A3: Subject Family History

ALS, Cognitive Impairment (CI) and Frontotemporal Lobar Dementia (FTLD): A Professional s Guide

Imaging in Dementia:

Visual Dysfunction in Alzheimer s Disease and Parkinson s Disease

Leah Militello, class of 2018

Imaging of Alzheimer s Disease: State of the Art

Neuro-Imaging in dementia: using MRI in routine work-up Prof. Philip Scheltens

Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit

Neuropsychological, Behavioral, and Anatomical Evolution in Right Temporal Variant Frontotemporal Dementia: A Longitudinal Single Case Analysis

Presenter Disclosure Information. I have no financial relationships to disclose:

Right and Left Medial Orbitofrontal Volumes Show an Opposite Relationship to Agreeableness in FTD

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)

Round table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation

ApoE, Brain Networks and Behavior: A Cautionary Tale

Lecture 42: Final Review. Martin Wessendorf, Ph.D.

Dementia and Alzheimer s disease

The ABCs of Dementia Diagnosis

Dementia: A Comprehensive Update Neuroimaging, CSF, and genetic biomarkers in dementia

What s New in Dementia?

Brain imaging for the diagnosis of people with suspected dementia

Y. Zhang N. Schuff S. Woolley. L. Boreta

Dementia is not normal aging!

Anosognosia, or loss of insight into one s cognitive

DEFINING THE NEUROPSYCHOLOGICAL AND NEUROIMAGING PHENOTYPE OF BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA SUBMITTED TO UNIVERSITY COLLEGE LONDON

Diffusion Tensor Imaging 12/06/2013

MRI of Pathological Aging Brain

Visual Rating Scale Reference Material. Lorna Harper Dementia Research Centre University College London

The Aging Brain The Aging Brain

Supplementary Online Content

Neuroimaging for dementia diagnosis. Guidance from the London Dementia Clinical Network

SWI including phase and magnitude images

Cognitive Aging: Defining normal vs. disease?

Transcription:

Diffusion Tensor Imaging in Dementia Howard Rosen UCSF Department of Neurology Memory and Aging Center www.memory.ucsf.edu

Overview Examples of DTI findings in Alzheimer s disease And other dementias Explore potential unique utility of DTI in assessment of dementia Examples MCI Cerebrovascular disease Frontotemporal dementia

Dementia causes cortical damage, and functional decline in a specific network of cortical regions dedicated to memory Network effects in Alzheimer s disease Traditional approaches to characterizing network problems in AD: FDG-PET SPECT Perfusion Whole brain volumetrics Brain volume Ventricular volume Regional volumetrics Hippocampus Entorhinal cortex Parietal cortex Cingulate cortex Frontal cortex from: Buckner et al, J Nsci, 2007

Dementia causes cortical damage, and functional decline in a specific network of cortical regions dedicated to memory This network is interconnected by specific white matter tracts Thalamocortical fibers Cingulate bundle Fornix Mamillothalamic tract from: Buckner et al, J Nsci, 2007 modified from: Papez, Arch Neurol Psychiatry 1937c

DTI in cingulum is abnormal in Alzheimer s and MCI Predictive of diagnosis beyond gray matter alone Zhang et al, Neurology, 2007

Cingulum MD is correlated with severity of cognitive impairment Nakata et al, Mag Res Imaging, 2009

FA AxD Diffusivity measures may be more sensitive than FA in dementia Acosta-Cabronero et al, Brain, 2010 RaD MD

DTI has been used in a variety of diseases that cause dementia Alzheimer s disease/mci Lewy body disease Vascular dementia Parkinson s disease Frontotemporal dementia Huntington s disease Creutzfeldt-Jakob disease HIV Normal pressure hydrocephalus

MD in striatum is increased in Huntington s disease gene carriers and associated with likelihood of impending symptoms Magnotta et al, Brain Imag Beh, 2011

FA is reduced in Parkinson s dementia/dlb FA is correlated with MMSE: Hattori et al, Human Brain Mapp, 2011

So, from a general review of DTI in dementia, what would one conclude? White matter abnormalities detectable Often in a pattern consistent with proposed network of degeneration Often persists after accounting for gray matter changes Sometimes correlated with gray matter changes Often correlate with measures of clinical severity Diffusivity may be more sensitive than FA DTI may also detect changes in predominantly gray matter structures What is the utility of these findings? We re just beginning, but some clues to potential uses are emerging

Prognosis: Regional DTI predicts conversion from MCI to AD (2 yr follow-up study) Scola et al, J. Neurol Neurosurg Psych, 2010

Increased sensitivity to pathology: White matter lesions associated with abnormalities in DTI (FA, D) in adjacent and distant regions Kuczynski et al, Alz and Dementia, 2010

Frontotemporal dementia (FTD): A behavioral syndrome Frontotemporal dementia Behavioral problems Disinhibition Apathy Emotional blunting Euphoria Obsessions and compulsions Mental rigidity Depression Cognitive deficits Poor planning Alzheimer s disease Behavioral problems Apathy Irritability/agitation Depression Cognitive deficits Memory loss Visual-spatial impairment Poor planning

Regions of gray matter atrophy in FTD and AD Right Hemisphere Left Hemisphere Bottom Mid-Sagittal Section FTD vs. Controls AD vs. Controls max t p<0.05, corrected for multiple comparisons min

Functional imaging/nuclear medicine techniques Structural MRI SPECT Perfusion, Varrone, 2002 VBM FTD FDG-PET, Foster, 2003 rsfmri, Zhou, 2010

DTI abnormalities are significant in FTD, are predominantly frontal and are worse than in AD Zhang et al, Brain, 2009

Variants of FTD Frontal variant: typical behavioral syndrome Temporal variant: Semantic dementia Left frontal opercular variant: Progressive nonfluent aphasia

DTI abnormalities in FTD variants associate with regional GM abnormalities Zhang et al, in preparation

WM abnormalities are at least as good as gray matter loss in differentiating FTLD from controls Strong effects for diffusivity

Emotion processing in FTD is correlated with FA in the Uncinate Fasciculus Independent of OFC and Anterior temporal gray matter volumes Dependent Variable: TASIT - EET Tartaglia et al, Submitted R UNC-OFC GM 0.64 1.35 0.19 R ANT TEMP GM -0.51-1.08 0.29 R Unc FA 0.50 2.62 0.013 Beta t Sig. Model Predictors Adj R Squ Sig. (Constant), R Unc FA, R OFC GM, R Ant temp GM 0.35 0.000

FA in Uncinate fasciculus is reduced in asymptomatic carriers of FTLD mutation No significant gray matter changes PNFA Borroni et al, Rejuvenation research, 2008

Possible unique role for DTI Increased sensitivity to pathology (e.g. vascular changes) Possible sensitivity to dual pathology (effects of vascular beyond neurodegeneration) Better characterization of some non-ad dementias, like FTD, where DTI is particularly abnormal Prognosis In MCI In mutation carriers (FTLD, HD, also AD) Longitudinal assessment AD, non-ad

Major efforts are ongoing to incorporate DTI into the study of degenerative disease Alzheimer s Disease Neuroimaging Initiative (ADNI) Frontotemporal Lobar Degeneration Meuroimaging Initiative (FTLDNI) Both longitudinal studies

Acknowledgments UCSF Memory and Aging Center Bruce Miller Carmela Tartaglia Joel Kramer Kate Rankin Bill Seeley Helen Zhou Maria-Luisa Gorno-Tempini Gil Rabinovici Adam Boxer Robin Ketelle Jennifer Merrilees Baber Khan Teresa Wu Marissa Urbano Wil Irwin Josiah Leong Lauren Homer Anna Karydas Trishna Subas Ken Edwards Reva Wilhelm Oscar Alcantar CIND Michael Weiner *Yu Zhang Norbert Schuff Duygu Tosun Diana Sacrey Sky Raptentsetsang

DTI may increase sensitivity to effects of dual pathology Lee et al, Stroke, 2010